Galactose Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Galactose, sometimes abbreviated Gal, is a monosaccharide sugar that is about as sweet as glucose, and about 65% as sweet as sucrose. It is an aldohexose and a C-4 epimer of glucose. A galactose molecule linked with a glucose molecule forms a lactose molecule.   Wikipedia

Chemistry

  • SMILES: OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O
  • InChIKey: WQZGKKKJIJFFOK-PHYPRBDBSA-N
  • Mol. Mass: 180.16
  • ALogP: -3.22
  • ChEMBL Molecule:
    galactose  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

alpha-d-galactopyranose | d-galactose | galactopyranose | galactose | levovist | microparticles of galactose | sh-ta-508 | shu 508 | shu-508 | shu 508 a

Organizations (25)

Research & Development (25)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (7)

Approved Indications (1)


 

Dietary Supplements

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

Congenital Disorders of Glycosylation (Phase 2)

Glomerulosclerosis, Focal Segmental (Phase 2)

Hepatitis C (Phase 4)

Ischemic Stroke (Phase 2)

Liver Diseases (Phase 3)

Liver Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial Organizations: 25

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue